Smartwatches for Detection of Atrial Fibrillation (AFib) in Secondary Prevention of Cryptogenic Stroke

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Germany

Klinikum rechts der Isar, Technische Universität München, Munich